These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 24392030)

  • 21. Axonal pathology in hPSC-based models of Parkinson's disease results from loss of Nrf2 transcriptional activity at the Map1b gene locus.
    Czaniecki C; Ryan T; Stykel MG; Drolet J; Heide J; Hallam R; Wood S; Coackley C; Sherriff K; Bailey CDC; Ryan SD
    Proc Natl Acad Sci U S A; 2019 Jul; 116(28):14280-14289. PubMed ID: 31235589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. α-Synuclein Overexpression Induces Lysosomal Dysfunction and Autophagy Impairment in Human Neuroblastoma SH-SY5Y.
    Nascimento AC; Erustes AG; Reckziegel P; Bincoletto C; Ureshino RP; Pereira GJS; Smaili SS
    Neurochem Res; 2020 Nov; 45(11):2749-2761. PubMed ID: 32915398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Roflupram attenuates α-synuclein-induced cytotoxicity and promotes the mitochondrial translocation of Parkin in SH-SY5Y cells overexpressing A53T mutant α-synuclein.
    Zhong J; Li M; Xu J; Dong W; Qin Y; Qiu S; Li X; Wang H
    Toxicol Appl Pharmacol; 2022 Feb; 436():115859. PubMed ID: 34990728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Authentically phosphorylated α-synuclein at Ser129 accelerates neurodegeneration in a rat model of familial Parkinson's disease.
    Sato H; Arawaka S; Hara S; Fukushima S; Koga K; Koyama S; Kato T
    J Neurosci; 2011 Nov; 31(46):16884-94. PubMed ID: 22090514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Caffeic acid reduces A53T α-synuclein by activating JNK/Bcl-2-mediated autophagy in vitro and improves behaviour and protects dopaminergic neurons in a mouse model of Parkinson's disease.
    Zhang Y; Wu Q; Zhang L; Wang Q; Yang Z; Liu J; Feng L
    Pharmacol Res; 2019 Dec; 150():104538. PubMed ID: 31707034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Baicalein reduces E46K alpha-synuclein aggregation in vitro and protects cells against E46K alpha-synuclein toxicity in cell models of familiar Parkinsonism.
    Jiang M; Porat-Shliom Y; Pei Z; Cheng Y; Xiang L; Sommers K; Li Q; Gillardon F; Hengerer B; Berlinicke C; Smith WW; Zack DJ; Poirier MA; Ross CA; Duan W
    J Neurochem; 2010 Jul; 114(2):419-29. PubMed ID: 20412383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Astrocyte-specific overexpression of Nrf2 delays motor pathology and synuclein aggregation throughout the CNS in the alpha-synuclein mutant (A53T) mouse model.
    Gan L; Vargas MR; Johnson DA; Johnson JA
    J Neurosci; 2012 Dec; 32(49):17775-87. PubMed ID: 23223297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alpha-Synuclein Preserves Mitochondrial Fusion and Function in Neuronal Cells.
    Faustini G; Marchesan E; Zonta L; Bono F; Bottani E; Longhena F; Ziviani E; Valerio A; Bellucci A
    Oxid Med Cell Longev; 2019; 2019():4246350. PubMed ID: 31871549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. α-Synuclein Mutation Inhibits Endocytosis at Mammalian Central Nerve Terminals.
    Xu J; Wu XS; Sheng J; Zhang Z; Yue HY; Sun L; Sgobio C; Lin X; Peng S; Jin Y; Gan L; Cai H; Wu LG
    J Neurosci; 2016 Apr; 36(16):4408-14. PubMed ID: 27098685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tetrahydroxystilbene glucoside inhibits α-synuclein aggregation and apoptosis in A53T α-synuclein-transfected cells exposed to MPP
    Zhang R; Sun F; Zhang L; Sun X; Li L
    Can J Physiol Pharmacol; 2017 Jun; 95(6):750-758. PubMed ID: 28187263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Curcumin protects against A53T alpha-synuclein-induced toxicity in a PC12 inducible cell model for Parkinsonism.
    Liu Z; Yu Y; Li X; Ross CA; Smith WW
    Pharmacol Res; 2011 May; 63(5):439-44. PubMed ID: 21237271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutant A53T alpha-synuclein induces neuronal death by increasing mitochondrial autophagy.
    Choubey V; Safiulina D; Vaarmann A; Cagalinec M; Wareski P; Kuum M; Zharkovsky A; Kaasik A
    J Biol Chem; 2011 Mar; 286(12):10814-24. PubMed ID: 21252228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipid metabolism alterations in the neuronal response to A53T α-synuclein and Fe-induced injury.
    Sánchez Campos S; Alza NP; Salvador GA
    Arch Biochem Biophys; 2018 Oct; 655():43-54. PubMed ID: 30098984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutant α-Synuclein Overexpression Induces Stressless Pacemaking in Vagal Motoneurons at Risk in Parkinson's Disease.
    Lasser-Katz E; Simchovitz A; Chiu WH; Oertel WH; Sharon R; Soreq H; Roeper J; Goldberg JA
    J Neurosci; 2017 Jan; 37(1):47-57. PubMed ID: 28053029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. E46K human alpha-synuclein transgenic mice develop Lewy-like and tau pathology associated with age-dependent, detrimental motor impairment.
    Emmer KL; Waxman EA; Covy JP; Giasson BI
    J Biol Chem; 2011 Oct; 286(40):35104-18. PubMed ID: 21846727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of human E46K mutant α-synuclein impairs macroautophagy via inactivation of JNK1-Bcl-2 pathway.
    Yan JQ; Yuan YH; Gao YN; Huang JY; Ma KL; Gao Y; Zhang WQ; Guo XF; Chen NH
    Mol Neurobiol; 2014 Oct; 50(2):685-701. PubMed ID: 24833599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Linking alpha-synuclein phosphorylation to reactive oxygen species formation and mitochondrial dysfunction in SH-SY5Y cells.
    Perfeito R; Lázaro DF; Outeiro TF; Rego AC
    Mol Cell Neurosci; 2014 Sep; 62():51-9. PubMed ID: 25109238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitochondrial division inhibitor-1 is neuroprotective in the A53T-α-synuclein rat model of Parkinson's disease.
    Bido S; Soria FN; Fan RZ; Bezard E; Tieu K
    Sci Rep; 2017 Aug; 7(1):7495. PubMed ID: 28790323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential regulation of wild-type and mutant alpha-synuclein binding to synaptic membranes by cytosolic factors.
    Wislet-Gendebien S; Visanji NP; Whitehead SN; Marsilio D; Hou W; Figeys D; Fraser PE; Bennett SA; Tandon A
    BMC Neurosci; 2008 Sep; 9():92. PubMed ID: 18808659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Axonal transport of human alpha-synuclein slows with aging but is not affected by familial Parkinson's disease-linked mutations.
    Li W; Hoffman PN; Stirling W; Price DL; Lee MK
    J Neurochem; 2004 Jan; 88(2):401-10. PubMed ID: 14690528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.